Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials.
Dou KX, Tan MS, Tan CC, Cao XP, Hou XH, Guo QH, Tan L, Mok V, Yu JT. Dou KX, et al. Alzheimers Res Ther. 2018 Dec 27;10(1):126. doi: 10.1186/s13195-018-0457-9. Alzheimers Res Ther. 2018. PMID: 30591071 Free PMC article.
BACKGROUND: Cholinesterase inhibitors and memantine have been approved for management of Alzheimer's disease (AD), but there has been no consensus about the choice of various types and doses of drugs at different stages. Hence, we comp
BACKGROUND: Cholinesterase inhibitors and memantine have been approved for management of Alzheimer's d
Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: systematic review and Bayesian network meta-analysis.
Jin BR, Liu HY. Jin BR, et al. Neural Regen Res. 2019 May;14(5):805-816. doi: 10.4103/1673-5374.249228. Neural Regen Res. 2019. PMID: 30688266 Free PMC article.
A Bayesian network meta-analysis was conducted. OUTCOME MEASURES: Efficacy was assessed by changes in scores of the Alzheimer's Disease Assessment Scale, cognitive subscale, Mini-Mental State Examination, Neuropsychiatric Inventory scores …
A Bayesian network meta-analysis was conducted. OUTCOME MEASURES: Efficacy was assessed by changes in scores of the …
Feedback